Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 28, 2010; 16(28): 3567-3572
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3567
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3567
Figure 1 Kaplan-Meier survival analysis of patients with T2 gallbladder carcinoma by ss score.
A: Disease-specific survival; the 5-year survival rate for ss min and ss med was 100%. In ss mas gallbladder carcinoma (GBCa), the 5-year survival rate was 59.7%; B: Disease-free survival; the 5-year survival rate for ss min and ss med was 100%. In ss mas GBCa, the 5-year survival rate was 56.6%.
- Citation: Kohya N, Kitahara K, Miyazaki K. Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread. World J Gastroenterol 2010; 16(28): 3567-3572
- URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3567.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3567